Literature DB >> 28316534

Halt and Reversal of Fibrosis.

Don C Rockey1.   

Abstract

Entities:  

Year:  2006        PMID： 28316534      PMCID： PMC5350576     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  4 in total

1.  Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival.

Authors:  Timothy R Morgan; David G Weiss; Bernard Nemchausky; Eugene R Schiff; Bhupinder Anand; Francis Simon; Jayashri Kidao; Bennet Cecil; Charles L Mendenhall; Douglas Nelson; Charles Lieber; Marcos Pedrosa; Lennox Jeffers; John Bloor; Lawrence Lumeng; Luis Marsano; Craig McClain; Girish Mishra; Brent Myers; Maria Leo; Yelena Ponomarenko; Derek Taylor; Antonio Chedid; Samuel French; Gary Kanel; Natalie Murray; Paul Pinto; Tse-Ling Fong; Mike R Sather
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

Review 2.  Reversal of hepatic fibrosis -- fact or fantasy?

Authors:  Scott L Friedman; Meena B Bansal
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

Review 3.  Antifibrotic therapy in chronic liver disease.

Authors:  Don C Rockey
Journal:  Clin Gastroenterol Hepatol       Date:  2005-02       Impact factor: 11.382

4.  II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease.

Authors:  Charles S Lieber; David G Weiss; Roberto Groszmann; Fiorenzo Paronetto; Steven Schenker
Journal:  Alcohol Clin Exp Res       Date:  2003-11       Impact factor: 3.455
  4 in total
  1 in total

Review 1.  Colchicine for prevention of cardiovascular events.

Authors:  Lars G Hemkens; Hannah Ewald; Viktoria L Gloy; Armon Arpagaus; Kelechi K Olu; Mark Nidorf; Dominik Glinz; Alain J Nordmann; Matthias Briel
Journal:  Cochrane Database Syst Rev       Date:  2016-01-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.